Securities and Exchange Commission
Washington, D.C. 20549
Information to be Included in Statements Filed Pursuant
to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed
Pursuant to § 240.13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. )*
Inari Medical, Inc.
(Name of Issuer)
Common Stock, par value $0.001
(Title of Class of Securities)
December 31, 2020
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|CUSIP No. 45332Y109||Schedule 13G||Page 1 of 4|
Names of Reporting Persons
Donald B. Milder
Check the Appropriate Box if a Member of a Group
(a) ☐ (b) ☐
SEC Use Only
Citizenship or Place of Organization
Sole Voting Power
Shared Voting Power
Sole Dispositive Power
Shared Dispositive Power
Aggregate Amount Beneficially Owned by Each Reporting Person
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
Percent of Class Represented by Amount in Row 9
Type of Reporting Person
|CUSIP No. 45332Y109||Schedule 13G||Page 2 of 4|
|ITEM 1. (a)|| |
Name of Issuer:
Inari Medical, Inc. (the Issuer).
Address of Issuers Principal Executive Offices:
9 Parker, Suite 100, Irvine, CA 92618.
|ITEM 2. (a)|| |
Name of Person Filing:
This statement is filed on behalf of Donald B. Milder (the Reporting Person).
Address or Principal Business Office:
The business address of the Reporting Person is c/o Inari Medical, Inc., 9 Parker, Suite 100, Irvine, CA 92618.
The Reporting Person is a citizen of the United States.
Title of Class of Securities:
Common stock, par value $0.001 per share (Common Stock).
|ITEM 3.|| |
|ITEM 4.|| |
The ownership information below represents beneficial ownership of shares of Common Stock as of December 31, 2020, based upon 48,710,821 shares of Common Stock outstanding as of November 6, 2020 based on the Issuers quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2020.
(a) Amount beneficially owned:
Consists of (i) 239,841 shares of Common Stock held directly by the Reporting Person and (ii) 5,026,614 shares of Common Stock held directly by Milder Community Property Trust, whereby the Reporting Person is the trustee.
|CUSIP No. 45332Y109||Schedule 13G||Page 3 of 4|
(b) Percent of class: 10.8%
(c) Number of shares as to which the person has:
Sole power to vote or to direct the vote: 5,266,455
Shared power to vote or direct the vote: 0
Sole power to dispose or to direct the disposition of: 5,266,455
Shared power to dispose or to direct the disposition of: 0
|ITEM 5.|| |
Ownership of Five Percent or Less of a Class.
|ITEM 6.|| |
Ownership of More than Five Percent on Behalf of Another Person.
|ITEM 7.|| |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
|ITEM 8.|| |
Identification and Classification of Members of the Group.
|ITEM 9.|| |
Notice of Dissolution of Group.
|ITEM 10.|| |
|CUSIP No. 45332Y109||Schedule 13G||Page 4 of 4|
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 8, 2021
|Donald B. Milder|
|/s/ Donald B. Milder|